₹ 103.2
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Weak growth
Data is available to registered users only
Data is available to registered users only
About
Tyche Industries Ltd. focuses on the production and refinement of active pharmaceutical compounds and their chemical precursors. The company's diverse product line includes specialized chiral intermediates and various nutraceuticals, all intended for use in treating a wide array of medical conditions. Established on July 23, 1998, the enterprise maintains its primary operations from its headquarters in Hyderabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITD.
Data is available to registered users only